UNITED THERAPEUTICS Corp - COM (UTHR)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
44 M
Holdings value Q1 2024
$10.1 B
Value change Q1 2024
+$34 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
497
Number of buys Q1 2024
251
Number of sells Q1 2024
-234
Average buys Q1 2024 %
+0.004%
Average sells Q1 2024 %
-0.004%
CUSIP
91307C102
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 44 M $10.1 B +$34 M $229.72 497
2023 Q4 43.1 M $9.46 B +$78.3 M $219.89 515
2023 Q3 43.5 M $9.82 B -$174 M $225.87 498
2023 Q2 43.9 M $9.7 B -$249 M $220.75 461
2023 Q1 44.6 M $9.99 B -$12.8 M $223.96 489
2022 Q4 44.2 M $12.3 B +$52.9 M $278.09 495
2022 Q3 43.4 M $9.08 B +$90.8 M $209.38 434
2022 Q2 42.9 M $10.1 B +$122 M $235.64 449
2022 Q1 43.4 M $7.78 B +$131 M $179.41 405
2021 Q4 42.6 M $9.2 B -$255 M $216.08 403
2021 Q3 43.5 M $8.03 B +$131 M $184.58 407
2021 Q2 43 M $7.71 B +$18.7 M $179.41 392
2021 Q1 42.2 M $7.06 B +$72.1 M $167.27 381
2020 Q4 42.9 M $6.51 B +$196 M $151.79 344
2020 Q3 41.4 M $4.19 B -$27 M $101.00 315
2020 Q2 42 M $5.08 B -$62.9 M $121.00 334
2020 Q1 42.3 M $4.01 B +$197 M $94.83 286
2019 Q4 41 M $3.61 B -$14.4 M $88.08 301
2019 Q3 40.5 M $3.23 B -$40 M $79.75 285
2019 Q2 40.9 M $3.19 B -$110 M $78.06 305
2019 Q1 42.5 M $4.98 B -$6.69 M $117.37 361
2018 Q4 42.7 M $4.64 B -$44.7 M $108.90 345
2018 Q3 42.4 M $5.41 B +$117 M $127.88 357
2018 Q2 42 M $4.75 B -$111 M $113.15 358
2018 Q1 43.3 M $4.85 B +$10.7 M $112.36 360
2017 Q4 43.1 M $6.36 B +$198 K $147.95 389
2017 Q3 43.7 M $5.12 B -$332 M $117.19 366
2017 Q2 46.2 M $6 B -$219 M $129.73 366
2017 Q1 47.6 M $6.45 B +$611 M $135.38 400
2016 Q4 46.8 M $6.71 B -$109 M $143.43 394
2016 Q3 48.6 M $5.73 B -$90.5 M $118.08 383
2016 Q2 49.3 M $5.22 B -$126 M $105.92 376
2016 Q1 50.6 M $5.64 B -$78.6 M $111.43 393
2015 Q4 49.7 M $7.79 B -$12 M $156.61 370
2015 Q3 49.9 M $6.55 B -$69.2 M $131.24 360
2015 Q2 50.4 M $8.76 B -$264 M $173.95 378
2015 Q1 52.4 M $9.02 B +$259 M $172.43 365
2014 Q4 50.5 M $6.54 B -$247 M $129.49 329
2014 Q3 52.8 M $6.8 B +$111 M $128.65 318
2014 Q2 52.2 M $4.62 B -$1.25 B $88.49 303
2014 Q1 53.4 M $5.02 B -$141 M $94.03 303